• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Virus Plus Cytokine Fight Primary and Metastatic Cancer

0
  • by alexperjescuadmin
  • in Oncology
  • — 15 Aug, 2007
Paul Fisher
Paul Fisher

REFERENCE: Meet the Professor Session, AACR 2007, Los Angeles
PAUL FISHER, Columbia University, New York
Patients with cancer could soon be treated with adenoviruses capable of infecting both primary and distant tumors, and simultaneously releasing cancer-fighting cytokines, according to Paul Fisher, who presented his group’s findings to the AACR Annual Meeting in Los Angeles. He told delegates about his group’s work in which “conditionally replication competent adenoviruses” have been used to treat animals, and how they release cytokine IL-24, which reaches primary and distant disease simultaneously through the bloodstream. During the conference he discussed his group’s latest data with Peter Goodwin, and speculated about the future potential of this approach in the clinical setting.

Virus Plus Cytokine Fight Primary and Metastatic Cancer

Tracy Batchelor
Tracy Batchelor
Judith Sebolt Leopold
Judith Sebolt
Leopold

Tyrosine Kinase Inhibitor Shrinks Tumors in Patients With Recurrent Glioblastoma

REFERENCE: ABSTRACT: 2118 American Association for Cancer Research, April 14-18, 2007, Los Angeles, CA
TRACY BATCHELOR, Massachusetts General Hospital, Boston
COMMENT: JUDITH SEBOLT LEOPOLD, Pfizer Global Research, Ann Arbor

A new drug has achieved 50% shrinkage of tumors in patients with refractory, recurrent glioblastoma. The agent, known by the code AZD 2171, is being investigated currently in a phase II study conducted for the National Cancer Institute. It has had a significant effect in more than half of the 31 patients under investigation whose disease was progressing after surgery, chemotherapy, and radiotherapy, and who have run out of other options for further treatment. Karen Regester interviewed Tracy Batchelor about the results he presented at the Annual Meeting of the AACR in Los Angeles. Judith Sebolt Leopold commented on the data presented by Tracy Batchelor.

To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.
Share

Tags: aacraboutagentaudiocancerchemotherapycommentsconferencecytokinediseasedrugdrugsepisodefindingsinfectioninfectionsinhibitorinhibitorsinterviewinterviewsinvestigationjournalmetastaticNewspatientpresentedradiotherapyrefractorystudysurgerytreatmenttumors

You may also like...

  • Oncology Times Broadcast News with the Audio Journal of Oncology – Cancer Related Fatigue Questionnaires Assessed Oncology Times Broadcast News with the Audio Journal of Oncology – Cancer Related Fatigue Questionnaires Assessed 6 Apr, 2009
  • ASCO Annual Meeting Daily News Podcasts – June 5th, 2007 ASCO Annual Meeting Daily News Podcasts – June 5th, 2007 5 Jun, 2007
  • Clifford Hudis, MD, Chief of the Breast Medicine Service at Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York Targeting Emerging Drugable Pathways in Breast Cancer—Clinical Potential Assessed 28 Mar, 2015
  • First Line PARP Inhibition For Ovarian Cancer Assessed First Line PARP Inhibition For Ovarian Cancer Assessed 2 Nov, 2018

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Earlier Interferon Reduces Disability in Patients With Multiple Sclerosis
  • Next story London School of Hygiene & Tropical Medicine Audio News
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • New Front Line Standard for Older Patients with…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Pembrolizumab: No Survival Gains Second Line In…
  • Home
  • Oncology
  • Virus Plus Cytokine Fight Primary and Metastatic Cancer

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.